Soheila Refahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Soheila Refahi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Mahdieh Afkhami Ardekani
Department of Radiology, Faculty of Para-Medicine, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran
3 shared publications Masoud Pourissa
Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 shared publications- Gholam Hassan Haddadi
Department of Radiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications - Parinaz Mehnati
Medical Radiation Sciences Research Center, Department of Medical Physics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Abbas Takavar
Department of Medical Physics and Biomedical Engineering, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Afrouz Mardi
Department of public Health, school of health, Ardabil university of medical science, Ardabil, Iran
1 shared publication
Latest Publications
- Open Access
Development of minimum data set and dashboard for monitoring adverse events in radiology departments
- 14 January 2023
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 54 (1) , 145-152
Trade-off between breast dose and image quality using composite bismuth shields in computed tomography: A phantom study
- 14 January 2023
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 54 (1) , 145-152
Trade-off between breast dose and image quality using composite bismuth shields in computed tomography: A phantom study
- 23 December 2022
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 16 (1) , 57-68
Shielding performance of multi-metal nanoparticle composites for diagnostic radiology: an MCNPX and Geant4 study
Lead-free polymer composite shields are used in diagnostic radiology to protect patients from unnecessary radiation exposure. This study aimed to examine and introduce the radiation-shielding properties of single- and multi-metal nanoparticle (NP)-based composites containing Bi, W, and Sn using Geant4, MCNPX, and XCom for radiological applications. The mass attenuation coefficients and effective atomic numbers of single- and multi-metal NP-loaded polymer composites were calculated using the Geant4 and MCNPX simulation codes for X-ray energies of 20–140 keV. The nano-sized fillers inside the polydimethylsiloxane (PDMS:C2H6SiO) matrix included W (K = 69.5 keV), Bi (K = 90.5 keV), and Sn (K = 29.20 keV). For single-metal shields, one filler was used, while in multi-metal shields, two fillers were required. The MCNPX and Geant4 simulation results were compared with the XCom results. The multi-metal NP composites exhibited higher attenuation over a larger energy range owing to their attenuation windows. In addition, Bi2O3 + WO3 NPs showed a 39% higher attenuation at 100–140 keV, and that of Bi2O3 + SnO2 NPs was higher at 40–60 keV. Meanwhile, the WO3 + SnO2 NPs exhibited lower attenuation. The difference between the results obtained using Geant4 and XCom was less than 2%, because these codes have similar simulation structures. The results show that the shielding performance of the Bi2O3 + WO3 filler is better than that of the other single- and multi-metal fillers. In addition, it was found that the Geant4 code was more accurate for simulating radiation composites.
- 23 December 2022
- Published by Springer Nature in Radiological Physics and Technology
- Vol. 16 (1) , 57-68
Shielding performance of multi-metal nanoparticle composites for diagnostic radiology: an MCNPX and Geant4 study
Lead-free polymer composite shields are used in diagnostic radiology to protect patients from unnecessary radiation exposure. This study aimed to examine and introduce the radiation-shielding properties of single- and multi-metal nanoparticle (NP)-based composites containing Bi, W, and Sn using Geant4, MCNPX, and XCom for radiological applications. The mass attenuation coefficients and effective atomic numbers of single- and multi-metal NP-loaded polymer composites were calculated using the Geant4 and MCNPX simulation codes for X-ray energies of 20–140 keV. The nano-sized fillers inside the polydimethylsiloxane (PDMS:C2H6SiO) matrix included W (K = 69.5 keV), Bi (K = 90.5 keV), and Sn (K = 29.20 keV). For single-metal shields, one filler was used, while in multi-metal shields, two fillers were required. The MCNPX and Geant4 simulation results were compared with the XCom results. The multi-metal NP composites exhibited higher attenuation over a larger energy range owing to their attenuation windows. In addition, Bi2O3 + WO3 NPs showed a 39% higher attenuation at 100–140 keV, and that of Bi2O3 + SnO2 NPs was higher at 40–60 keV. Meanwhile, the WO3 + SnO2 NPs exhibited lower attenuation. The difference between the results obtained using Geant4 and XCom was less than 2%, because these codes have similar simulation structures. The results show that the shielding performance of the Bi2O3 + WO3 filler is better than that of the other single- and multi-metal fillers. In addition, it was found that the Geant4 code was more accurate for simulating radiation composites.
- Open Access
- 6 October 2021
- Published by Springer Nature in Research Square
Health Information from Management to Technology: Development of a Radiology Patient Safety Monitoring System
Background: Medical imaging is an intervention through which patient safety (PS) is of great importance. In monitoring PS, the major challenges include lack of relevant data, proper control, and appropriate feedback in taking the necessary measures. To meet these deficiencies, the related data should be investigated precisely and advanced technology should be applied to monitor the quality of imaging.Objective: The purpose of this study was to design and develop a PS monitoring system at the radiology department to mitigate adverse events.Methods: This developmental research was conducted in multiple phases including content determination using Delphi technique, conceptual modeling using Rational Rose software, database designing using SQL Server, user interface (UI) building using Agile software, and system evaluating in three aspects of UI requirements, the accuracy of calculating, and usability. Results: In this study, 110 PS-related important data elements were identified in 14 main groups and 26 PS performance metrics, as the system contents. The ERD and UML diagrams were drawn and the UI was created in three tabs: pre-procedure, intra-procedure, and post-procedure. Finally, the evaluation results proved the technical feasibility and application prospect of the radiology patient safety monitoring system (RPSMS). Finally, the usability of the system was highly rated (76.3 from 100).Conclusion: The RPSMS, offers the possibility to complement the datasheets for gaining a more accurate picture of the PS status and bringing up its aspects, which might otherwise go unnoticed or be underestimated by clinicians.
- 6 October 2021
- Published by Springer Nature in Research Square
Open AccessHealth Information from Management to Technology: Development of a Radiology Patient Safety Monitoring System
Background: Medical imaging is an intervention through which patient safety (PS) is of great importance. In monitoring PS, the major challenges include lack of relevant data, proper control, and appropriate feedback in taking the necessary measures. To meet these deficiencies, the related data should be investigated precisely and advanced technology should be applied to monitor the quality of imaging.Objective: The purpose of this study was to design and develop a PS monitoring system at the radiology department to mitigate adverse events.Methods: This developmental research was conducted in multiple phases including content determination using Delphi technique, conceptual modeling using Rational Rose software, database designing using SQL Server, user interface (UI) building using Agile software, and system evaluating in three aspects of UI requirements, the accuracy of calculating, and usability. Results: In this study, 110 PS-related important data elements were identified in 14 main groups and 26 PS performance metrics, as the system contents. The ERD and UML diagrams were drawn and the UI was created in three tabs: pre-procedure, intra-procedure, and post-procedure. Finally, the evaluation results proved the technical feasibility and application prospect of the radiology patient safety monitoring system (RPSMS). Finally, the usability of the system was highly rated (76.3 from 100).Conclusion: The RPSMS, offers the possibility to complement the datasheets for gaining a more accurate picture of the PS status and bringing up its aspects, which might otherwise go unnoticed or be underestimated by clinicians.
- Open Access
- 30 March 2021
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 26 (4) , 635-646
A historical literature review on the role of posterior axillary boost field in the axillary lymph node coverage and development of lymphedema following regional nodal irradiation in breast cancer
To elucidate whether (1) a posterior axillary boost (PAB) field is an optimal method to target axillary lymph nodes (LNs); and (2) the addition of a PAB increases the incidence of lymphedema, a systematic review was undertaken. A literature search was performed in the PubMed database. A total of 16 studies were evaluated. There were no randomized studies. Seven articles have investigated dosimetric aspects of a PAB. The remaining 9 articles have determined the effect of a PAB field on the risk of lymphedema. Only 2 of 9 articles have prospectively reported the impact of a PAB on the risk of lymphedema development. There are conflicting reports on the necessity of a PAB. The PAB field provides a good coverage of level I/II axillary LNs because these nodes are usually at a greater depth. The main concern regarding a PAB is that it produces a hot spot in the anterior region of the axilla. Planning studies optimized a traditional PAB field. Prospective studies and the vast majority of retrospective studies have reported the use of a PAB field does not result in increasing the risk of lymphedema development over supraclavicular-only field. The controversies in the incidence of lymphedema suggest that field design may be more important than field arrangement. A key factor regarding the use of a PAB is the depth of axillary LNs. The PAB field should not be used unless there is an absolute indication for its application. Clinicians should weigh lymphedema risk in individual patients against the limited benefit of a PAB, in particular after axillary dissection. The testing of the inclusion of upper arm lymphatics in the regional LN irradiation target volume, and universal methodology measuring lymphedema are all areas for possible future studies. ?: To elucidate whether (1) a posterior axillary boost (PAB) field is an optimal method to target axillary lymph nodes (LNs); and (2) the addition of a PAB increases the incidence of lymphedema, a systematic review was undertaken. A literature search was performed in the PubMed database. A total of 16 studies were evaluated. There were no randomized studies. Seven articles have investigated dosimetric aspects of a PAB. The remaining 9 articles have determined the effect of a PAB field on the risk of lymphedema. Only 2 of 9 articles have prospectively reported the impact of a PAB on the risk of lymphedema development. There are conflicting reports on the necessity of a PAB. The PAB field provides a good coverage of level I/II axillary LNs because these nodes are usually at a greater depth. The main concern regarding a PAB is that it produces a hot spot in the anterior region of the axilla. Planning studies optimized a traditional PAB field. Prospective studies and the vast majority of retrospective studies have reported the use of a PAB field does not result in increasing the risk of lymphedema development over supraclavicular-only field. The controversies in the incidence of lymphedema suggest that field design may be more important than field arrangement. A key factor regarding the use of a PAB is the depth of axillary LNs. The PAB field should not be used unless there is an absolute indication for its application. Clinicians should weigh lymphedema risk in individual patients against the limited benefit of a PAB, in particular after axillary dissection. The testing of the inclusion of upper arm lymphatics in the regional LN irradiation target volume, and universal methodology measuring lymphedema are all areas for possible future studies. ?:
- 30 March 2021
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 26 (4) , 635-646
Open AccessA historical literature review on the role of posterior axillary boost field in the axillary lymph node coverage and development of lymphedema following regional nodal irradiation in breast cancer
To elucidate whether (1) a posterior axillary boost (PAB) field is an optimal method to target axillary lymph nodes (LNs); and (2) the addition of a PAB increases the incidence of lymphedema, a systematic review was undertaken. A literature search was performed in the PubMed database. A total of 16 studies were evaluated. There were no randomized studies. Seven articles have investigated dosimetric aspects of a PAB. The remaining 9 articles have determined the effect of a PAB field on the risk of lymphedema. Only 2 of 9 articles have prospectively reported the impact of a PAB on the risk of lymphedema development. There are conflicting reports on the necessity of a PAB. The PAB field provides a good coverage of level I/II axillary LNs because these nodes are usually at a greater depth. The main concern regarding a PAB is that it produces a hot spot in the anterior region of the axilla. Planning studies optimized a traditional PAB field. Prospective studies and the vast majority of retrospective studies have reported the use of a PAB field does not result in increasing the risk of lymphedema development over supraclavicular-only field. The controversies in the incidence of lymphedema suggest that field design may be more important than field arrangement. A key factor regarding the use of a PAB is the depth of axillary LNs. The PAB field should not be used unless there is an absolute indication for its application. Clinicians should weigh lymphedema risk in individual patients against the limited benefit of a PAB, in particular after axillary dissection. The testing of the inclusion of upper arm lymphatics in the regional LN irradiation target volume, and universal methodology measuring lymphedema are all areas for possible future studies. ?: To elucidate whether (1) a posterior axillary boost (PAB) field is an optimal method to target axillary lymph nodes (LNs); and (2) the addition of a PAB increases the incidence of lymphedema, a systematic review was undertaken. A literature search was performed in the PubMed database. A total of 16 studies were evaluated. There were no randomized studies. Seven articles have investigated dosimetric aspects of a PAB. The remaining 9 articles have determined the effect of a PAB field on the risk of lymphedema. Only 2 of 9 articles have prospectively reported the impact of a PAB on the risk of lymphedema development. There are conflicting reports on the necessity of a PAB. The PAB field provides a good coverage of level I/II axillary LNs because these nodes are usually at a greater depth. The main concern regarding a PAB is that it produces a hot spot in the anterior region of the axilla. Planning studies optimized a traditional PAB field. Prospective studies and the vast majority of retrospective studies have reported the use of a PAB field does not result in increasing the risk of lymphedema development over supraclavicular-only field. The controversies in the incidence of lymphedema suggest that field design may be more important than field arrangement. A key factor regarding the use of a PAB is the depth of axillary LNs. The PAB field should not be used unless there is an absolute indication for its application. Clinicians should weigh lymphedema risk in individual patients against the limited benefit of a PAB, in particular after axillary dissection. The testing of the inclusion of upper arm lymphatics in the regional LN irradiation target volume, and universal methodology measuring lymphedema are all areas for possible future studies. ?:
- 3 March 2020
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 34 (6) , e22479
Radioprotective effects of montelukast, a selective leukotriene CysLT1 receptor antagonist, against nephrotoxicity induced by gamma radiation in mice
Purpose: In this study, we evaluated the renal protective effects of montelukast (MLK) against ionizing radiation (IR) induced nephrotoxicity in mice.Materials and Methods: Radioprotective effects of MLK were assessed by biochemical analysis including measurements of kidney malondialdehyde (MDA), reduced glutathione (GSH), and serum creatinine and urea levels. Besides, for further evaluation of protective effects of MLK on renal system, 99mTc‐dimercaptosuccinic acid (DMSA) has been applied. The total antioxidant capacity of MLK was measured by using 1,1‐diphenyl‐2‐picryl hydrazyl radical reagents and compared with butylated hydroxyl toluene standard antioxidant.Results: The biochemical evaluation revealed that better results have been achieved for the groups administered with MLK than the only radiation group. Besides only IR‐treated mice group, those treated with MLK demonstrated a significant decrease in urea and creatinine levels. Statistically, significant differences of MDA and SHG levels (P < .05) were found between the radiation group and MLK plus IR‐treated group. Also, 99mTc‐DMSA kidney uptake value (%ID/g) was observed lower for MLK plus IR‐treated mice group than only radiation‐treated mice group.Conclusions: According to our findings, MLK has a potential role to be used as a renal protective agent against gamma radiation in radiotherapy.
- 3 March 2020
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 34 (6) , e22479
Radioprotective effects of montelukast, a selective leukotriene CysLT1 receptor antagonist, against nephrotoxicity induced by gamma radiation in mice
Purpose: In this study, we evaluated the renal protective effects of montelukast (MLK) against ionizing radiation (IR) induced nephrotoxicity in mice.Materials and Methods: Radioprotective effects of MLK were assessed by biochemical analysis including measurements of kidney malondialdehyde (MDA), reduced glutathione (GSH), and serum creatinine and urea levels. Besides, for further evaluation of protective effects of MLK on renal system, 99mTc‐dimercaptosuccinic acid (DMSA) has been applied. The total antioxidant capacity of MLK was measured by using 1,1‐diphenyl‐2‐picryl hydrazyl radical reagents and compared with butylated hydroxyl toluene standard antioxidant.Results: The biochemical evaluation revealed that better results have been achieved for the groups administered with MLK than the only radiation group. Besides only IR‐treated mice group, those treated with MLK demonstrated a significant decrease in urea and creatinine levels. Statistically, significant differences of MDA and SHG levels (P < .05) were found between the radiation group and MLK plus IR‐treated group. Also, 99mTc‐DMSA kidney uptake value (%ID/g) was observed lower for MLK plus IR‐treated mice group than only radiation‐treated mice group.Conclusions: According to our findings, MLK has a potential role to be used as a renal protective agent against gamma radiation in radiotherapy.
- Open Access
- 1 January 2018
- Published by Wolters Kluwer Health in Journal of Medical Signals & Sensors
- Vol. 8 (3) , 195-203
Different dosimeters/detectors used in small-field dosimetry: Pros and cons
With the advent of complex and precise radiation therapy techniques, the use of relatively small fields is needed. Using such field sizes can cause uncertainty in dosimetry; therefore, special attention is required both in dose calculations and measurements. There are several challenges in small-field dosimetry such as the steep gradient of the radiation field, volume averaging effect, lack of charged particle equilibrium, partial occlusion of radiation source, beam alignment, and unable to use a reference dosimeter. Due to these challenges, special dosimeters are needed for small-field dosimetry, and this review article discusses this topic.
- 1 January 2018
- Published by Wolters Kluwer Health in Journal of Medical Signals & Sensors
- Vol. 8 (3) , 195-203
Open AccessDifferent dosimeters/detectors used in small-field dosimetry: Pros and cons
With the advent of complex and precise radiation therapy techniques, the use of relatively small fields is needed. Using such field sizes can cause uncertainty in dosimetry; therefore, special attention is required both in dose calculations and measurements. There are several challenges in small-field dosimetry such as the steep gradient of the radiation field, volume averaging effect, lack of charged particle equilibrium, partial occlusion of radiation source, beam alignment, and unable to use a reference dosimeter. Due to these challenges, special dosimeters are needed for small-field dosimetry, and this review article discusses this topic.
- Open Access
- 13 April 2017
- Published by Brieflands in Iranian Journal of Radiology
- Vol. Special is (5)
Brain Near-Infrared Spectroscopy (NIRS)
Brain Near-Infrared Spectroscopy (NIRS) - Iranian Journal of Radiology - - Kowsar
- 13 April 2017
- Published by Brieflands in Iranian Journal of Radiology
- Vol. Special is (5)
Open AccessBrain Near-Infrared Spectroscopy (NIRS)
Brain Near-Infrared Spectroscopy (NIRS) - Iranian Journal of Radiology - - Kowsar
- Open Access
- 21 March 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 13 (2) , e21012
Histopathological Evaluation of the Effectiveness of Glycyrrhizic Acid as a Radioprotector Against the Development of Radiation-Induced Lung Fibrosis
Background: Radiotherapy of the thorax often causes lung inflammation leading to fibrosis. Objectives: The aim of this study was to investigate whether the use of glycyrrhizic acid (GLA) could improve the development of lung fibrosis in irradiated animals. Materials and Methods: Wistar rats were divided into four groups. Group A rats received thoracic irradiation. Rats in group B received GLA and irradiation. Group C received GLA and no irradiation. Group D received no GLA and irradiation. GLA was administered at a dose of 4 mg/kg body weight using an intraperitoneal injection one hour before thoracic irradiation. Radiation therapy was delivered on a Cobalt-60 unit using a single fraction of 16 Gy. The animals were sacrificed at 32 weeks following thoracic irradiation. The lungs were dissected and blind histopathological evaluation was performed. Results: Histopathologically, a decrease (statistically not significant) in the thickening of alveolar or bronchial wall, formation of fibrous bands, and superimposed collagen were noted in the animals in group B as compared to the animals in group A. Conclusion: In this experimental study, administration of GLA one hour before thoracic irradiation may be a protective agent against radiation-induced fibrosis in animals and this model could be used in future studies. Keywords: Lung fibrosis; Radioprotector; Glycyrrhizic Acid; Histopathology
- 21 March 2016
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 13 (2) , e21012
Open AccessHistopathological Evaluation of the Effectiveness of Glycyrrhizic Acid as a Radioprotector Against the Development of Radiation-Induced Lung Fibrosis
Background: Radiotherapy of the thorax often causes lung inflammation leading to fibrosis. Objectives: The aim of this study was to investigate whether the use of glycyrrhizic acid (GLA) could improve the development of lung fibrosis in irradiated animals. Materials and Methods: Wistar rats were divided into four groups. Group A rats received thoracic irradiation. Rats in group B received GLA and irradiation. Group C received GLA and no irradiation. Group D received no GLA and irradiation. GLA was administered at a dose of 4 mg/kg body weight using an intraperitoneal injection one hour before thoracic irradiation. Radiation therapy was delivered on a Cobalt-60 unit using a single fraction of 16 Gy. The animals were sacrificed at 32 weeks following thoracic irradiation. The lungs were dissected and blind histopathological evaluation was performed. Results: Histopathologically, a decrease (statistically not significant) in the thickening of alveolar or bronchial wall, formation of fibrous bands, and superimposed collagen were noted in the animals in group B as compared to the animals in group A. Conclusion: In this experimental study, administration of GLA one hour before thoracic irradiation may be a protective agent against radiation-induced fibrosis in animals and this model could be used in future studies. Keywords: Lung fibrosis; Radioprotector; Glycyrrhizic Acid; Histopathology
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Medical Physics
- Vol. 40 (2) , 95-101
Modulation expression of tumor necrosis factor α in the radiation-induced lung injury by glycyrrhizic acid
To evaluate the ability of glycyrrhizic acid (GLA) to reduce the tumor necrosis factor α (TNF-α), release on messenger ribonucleic acid (mRNA) and protein production in the lungs using GLA in response to irradiation were studied. The animals were divided into four groups: No treatment (NT group), GLA treatment only (GLA group), irradiation only (XRT group), and GLA treatment plus irradiation (GLA/XRT group). Rats were killed at different time points. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to evaluate the mRNA expression of TNF-α in the lungs (compared with non-irradiated lungs). An enzyme-linked immunosorbant assay (ELISA) assay was used to measure the TNF-α protein level. The TNF-α mRNA expression in the lungs of the XRT rats was clearly higher at all-time points compared to the NT rats. The TNF-α mRNA expression in the lungs of the GLA/XRT rats was lower at all-time points compared to the XRT rats. Release of the TNF-α on protein level in the lungs of the XRT rats increased at all-time points compared to the NT rats. In contrast to the XRT rats, the lungs of the GLA/XRT rats revealed a reduction on TNF-α protein level at 6 h after irradiation. This study has clearly showed the immediate down-regulation of the TNF-α mRNA and protein production in the lungs using GLA in response to irradiation.
- 1 January 2015
- Published by Medknow in Journal of Medical Physics
- Vol. 40 (2) , 95-101
Open AccessModulation expression of tumor necrosis factor α in the radiation-induced lung injury by glycyrrhizic acid
To evaluate the ability of glycyrrhizic acid (GLA) to reduce the tumor necrosis factor α (TNF-α), release on messenger ribonucleic acid (mRNA) and protein production in the lungs using GLA in response to irradiation were studied. The animals were divided into four groups: No treatment (NT group), GLA treatment only (GLA group), irradiation only (XRT group), and GLA treatment plus irradiation (GLA/XRT group). Rats were killed at different time points. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to evaluate the mRNA expression of TNF-α in the lungs (compared with non-irradiated lungs). An enzyme-linked immunosorbant assay (ELISA) assay was used to measure the TNF-α protein level. The TNF-α mRNA expression in the lungs of the XRT rats was clearly higher at all-time points compared to the NT rats. The TNF-α mRNA expression in the lungs of the GLA/XRT rats was lower at all-time points compared to the XRT rats. Release of the TNF-α on protein level in the lungs of the XRT rats increased at all-time points compared to the NT rats. In contrast to the XRT rats, the lungs of the GLA/XRT rats revealed a reduction on TNF-α protein level at 6 h after irradiation. This study has clearly showed the immediate down-regulation of the TNF-α mRNA and protein production in the lungs using GLA in response to irradiation.